---
title: "Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | CADL Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286413140.md"
description: "Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | CADL Stock News"
datetime: "2026-05-14T04:05:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286413140.md)
  - [en](https://longbridge.com/en/news/286413140.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286413140.md)
---

# Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | CADL Stock News

Candel Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | CADL Stock News

### Related Stocks

- [CADL.US](https://longbridge.com/en/quote/CADL.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [Candel Therapeutics Reports Positive Phase 3 Prostate Cancer Trial Data](https://longbridge.com/en/news/286652611.md)
- [Candel Therapeutics reports Q1 loss](https://longbridge.com/en/news/286414971.md)
- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)